
Publikationen von B. Kalbfuss
Alle Typen
Zeitschriftenartikel (7)
1.
Zeitschriftenartikel
873 (1), S. 102 - 112 (2008)
Size-exclusion chromatography as a linear transfer system: Purification of human influenza virus as an example. Journal of Chromatography B 2.
Zeitschriftenartikel
36 (3), S. 145 - 161 (2008)
Monitoring Influenza Virus Content in Vaccine Production: Precise Assays for the Quantitation of Hemagglutination and Neuraminidase Activity. Biologicals 3.
Zeitschriftenartikel
97 (1), S. 73 - 85 (2007)
Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnology and Bioengineering 4.
Zeitschriftenartikel
299, S. 251 - 260 (2007)
Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. Journal of Membrane Science 5.
Zeitschriftenartikel
96, S. 932 - 944 (2007)
Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnology and Bioengineering 6.
Zeitschriftenartikel
10 (4), S. 18 - 20 (2006)
Preparative Size-Exclusion Chromatography. GIT Laboratory Journal Europe 7.
Zeitschriftenartikel
92 (2), S. 199 - 208 (2005)
Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Biotechnology and Bioengineering Vortrag (9)
8.
Vortrag
Characterization and analytical issues on an influenza A virus production process. Vaccines : Quality control, scale-up and manufacture, Hamburg, Germany (2006)
9.
Vortrag
Maximizing productivity in size-exclusion chromatography of influenza virus: A modelling approach. ESBES 6 : 6th European Symposium on Biochemical Engineering Science, Salzburg, Austria (2006)
10.
Vortrag
Konzentrierung und Aufreinigung von Influenza Viren mittels Ionenaustauscher-Membranen. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
11.
Vortrag
A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culture. Vaccine Technology, Puerto Vallarta, Mexico (2006)
12.
Vortrag
Chromatography-based purification of influenza A virus for the production of human whole-virion vaccines. ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and Polynucleotides, Innsbruck, Austria (2006)
13.
Vortrag
Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza Virus. BioProcess Technology - Asia, Singapore (2006)
14.
Vortrag
Downstream Process of Influenza Viruses. European BioPharm Scale-Up Congress 2006, Geneva, Switzerland (2006)
15.
Vortrag
Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Viral Vectors and Vaccines Conference, Austin, Texas (2005)
16.
Vortrag
Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccines. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)
Poster (3)
17.
Poster
Lectin-affinity purification of cell culture derived human Influenza A viruses. Vaccine Technology 2006, Puerto Vallarta, Mexico (2006)
18.
Poster
Generic Process Scheme for Particle-Based Purification of Cell Culture Derived Influenza A Virus. Bioperspectives, Wiesbaden, Germany (2005)
19.
Poster
Tangential Flow Filtration of Influenza Virus as a Model System. Engineering with Membranes, Camogli, Italy (2005)
Hochschulschrift - Doktorarbeit (1)
20.
Hochschulschrift - Doktorarbeit
Downstream Processing of Influenza Whole-Virions for Vaccine Production. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2009)